Abstract
It is hoped that over the next few years, some of these promising therapies will be fully evaluated in the clinical context with the ultimate aim to reduce the major economical and medical burden of diabetes, its vascular complications.
Keywords
GlycationMethylglyoxalDiabetes mellitusOxidative stressProinflammatory cytokineContext (archaeology)ReceptorMedicineRage (emotion)InflammationChemistryInternal medicineEndocrinologyBiologyBiochemistryNeuroscience
MeSH Terms
Diabetes ComplicationsDiabetic NephropathiesDiabetic NeuropathiesDiabetic RetinopathyDisease ProgressionGlycation End ProductsAdvancedHumansReceptor for Advanced Glycation End ProductsReceptorsImmunologic
Affiliated Institutions
Related Publications
Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe
Abstract Chronic infections, obesity, alcohol, tobacco, radiation, environmental pollutants, and high-calorie diet have been recognized as major risk factors for the most common...
Publication Info
- Year
- 2008
- Type
- review
- Volume
- 93
- Issue
- 4
- Pages
- 1143-1152
- Citations
- 968
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
968
OpenAlex
26
Influential
789
CrossRef
Cite This
Su‐Yen Goh,
Mark E. Cooper
(2008).
The Role of Advanced Glycation End Products in Progression and Complications of Diabetes.
The Journal of Clinical Endocrinology & Metabolism
, 93
(4)
, 1143-1152.
https://doi.org/10.1210/jc.2007-1817
Identifiers
- DOI
- 10.1210/jc.2007-1817
- PMID
- 18182449